31-Dec-23 | 31-Dec-22 | 31-Dec-21 | 31-Dec-20 | 31-Dec-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Rest of World | n/a | n/a | n/a | n/a | n/a | n/a | 182.00 | 28% | 189.00 | 24% |
Unanalysed | 176.00 | 16% | 164.00 | 18% | 181.00 | 23% | n/a | n/a | n/a | n/a |
United Kingdom | 5.00 | n/a | 6.00 | 1% | 7.00 | 1% | 9.00 | 1% | 7.00 | 1% |
United States | 912.00 | 83% | 731.00 | 81% | 603.00 | 76% | 456.00 | 70% | 589.00 | 75% |
Total | 1,093.00 | 100% | 901.00 | 100% | 791.00 | 100% | 647.00 | 100% | 785.00 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 1.00 | 100% | (95.00) | 100% | 190.00 | 100% | (173.00) | 100% | 180.00 | 100% |
Total | 1.00 | 100% | (95.00) | 100% | 190.00 | 100% | (173.00) | 100% | 180.00 | 100% |
31-Dec-23 | 31-Dec-22 | 31-Dec-21 | 31-Dec-20 | 31-Dec-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
PERSERIS | 42.00 | 4% | 28.00 | 3% | 17.00 | 2% | 14.00 | 2% | 6.00 | 1% |
SUBLOCADE | 630.00 | 58% | 408.00 | 45% | 244.00 | 31% | 130.00 | 20% | 72.00 | 9% |
Sublingual / Other | n/a | n/a | n/a | n/a | 530.00 | 67% | 503.00 | 78% | 707.00 | 90% |
Sublingual/Other 421 465 | 421.00 | 39% | 465.00 | 52% | n/a | n/a | n/a | n/a | n/a | n/a |
Total | 1,093.00 | 100% | 901.00 | 100% | 791.00 | 100% | 647.00 | 100% | 785.00 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 1.00 | n/a | (95.00) | n/a | 190.00 | n/a | (173.00) | n/a | 180.00 | n/a |
Total | 1.00 | n/a | (95.00) | n/a | 190.00 | n/a | (173.00) | n/a | 180.00 | n/a |
You are here: research